Class Certified In Securities Lawsuit Against Drug Company, Others

(December 19, 2017, 1:30 PM EST) -- SANTA ANA, Calif. — Certification of a class of investors in a securities lawsuit against pharmaceutical company Puma Biotechnology Inc. and certain of its executive officers is proper because the lead...
To view the full article, register now.